BackSanthera Pharmaceuticals Holding AG Overview
Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG Return on Equity

Santhera Pharmaceuticals Holding AG (SPHDF) has a ROE of 1579.02%, above the Healthcare sector average of -75.59%.

Get informed when a big investor buys or sells

+ Follow

ROE

1579.02%

Return on Equity

1579.02%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Santhera Pharmaceuticals Holding AG (SPHDF) FAQ

As of the most recent data, SPHDF shows a ROE of 1579.02%. That is above the Healthcare sector average of -75.59%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about -75.59%. Santhera Pharmaceuticals Holding AG is at 1579.02%, which is higher that average. That is roughly 2188.9% above the sector mean. Use the comparison chart on this page to see how SPHDF stacks up against individual peers as well.

Check the historical chart to see whether SPHDF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Santhera Pharmaceuticals Holding AG with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Santhera Pharmaceuticals Holding AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 1579.02%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about -75.59%, while SPHDF is at 1579.02%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.